Last Price
395.21
Today's Change
+4.14 (1.05%)
Day's Change
393.18 - 398.71
Trading Volume
71,419
Market Cap
12 Billion
Shares Outstanding
30 Million
Avg Volume
285,698
Avg Price (50 Days)
398.06
Avg Price (200 Days)
306.74
PE Ratio
40.27
EPS
9.82
Earnings Announcement
22-Jul-2024
Previous Close
391.07
Open
396.79
Day's Range
393.18 - 398.715
Year Range
197.39 - 421.0
Trading Volume
74,353
1 Day Change
1.11%
5 Day Change
0.95%
1 Month Change
-0.18%
3 Month Change
33.76%
6 Month Change
44.21%
Ytd Change
29.40%
1 Year Change
92.44%
3 Year Change
135.32%
5 Year Change
584.72%
10 Year Change
1322.90%
Max Change
1322.90%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.